← FDA Drug Approvals (Drugs@FDA)
CEFDINIR
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2021-02-19
Drug application
- FDA Application #
ANDA210220- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CEFDINIR
- Generic name
- CEFDINIR
- Active ingredients
- CEFDINIR
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALKEM LABS LTD
- Manufacturer
- American Health Packaging
- First approval
- 2021-02-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown